Morgan Stanley PE Asia

Premium

General

20 August, 2024

Grapevine: PEs eye India's largest cardiac stent maker; O2 Power race heats up

Private equity firms KKR, TPG Capital and Apax Partners are evaluating India's largest cardiac stent maker Sahajanand Medical Technologies (SMT), valuing the company at ......

Premium

Healthcare

17 June, 2024

Morgan Stanley PE emerges frontrunner to bet on urology chain

Morgan Stanley Private Equity Asia has emerged as one of the frontrunners to invest in an Indian healthcare company that ......

Premium

Healthcare

10 February, 2021

Bulk drugs maker to pop out ‘benchmark returns' pill for Morgan Stanley

ZCL Chemicals Ltd is all set to serve up benchmark returns for Morgan Stanley PE Asia as the investor gets ......

Premium

Finance

09 October, 2020

Company watch: Will virus cause only a blip in Creador-backed Kogta's rapid growth?

Non-bank lender Kogta Financial (India) Ltd aims to diversify its loan book and expects to improve profitability over the next ......

Premium

Healthcare

23 July, 2020

Morgan Stanley PE moves to exit another healthcare portfolio firm

Morgan Stanley Private Equity Asia has decided to exit an Indian healthcare portfolio company as transactions in the sector pick ......